About Osama Zaidat
Form D filings for Galaxy Therapeutics from 2020 to 2024 list Osama Zaidat as executive officer and director.
Osama Zaidat first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Osama Zaidat in the role, so the role may have started earlier or lasted longer.